BRIEF published on 01/29/2025 at 12:31, 1 year ago Sartorius Stedim Biotech: Preliminary Results 2024 EBITDA Sartorius Turnover Results 2024 Outlook 2025
BRIEF published on 01/28/2025 at 07:09, 1 year ago Sartorius Stedim Biotech Reveals Preliminary 2024 Financial Results Profitability Order Intake Sartorius Stedim Biotech Sales Revenue Financial Results 2024
PRESS RELEASE published on 01/28/2025 at 07:04, 1 year ago Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024, meeting revenue and profitability targets. Cautiously positive outlook for 2025 with profitable growth expected Financial Results Sartorius Stedim Biotech Profitable Growth Outlook 2024
BRIEF published on 01/07/2025 at 10:18, 1 year ago Half-yearly report on the liquidity contract of Sartorius Stedim Biotech Liquidity Contract Transactions Kepler Cheuvreux Half-yearly Report Sartorius Stedim Biotech
PRESS RELEASE published on 01/07/2025 at 10:13, 1 year ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech S.A. releases half-year liquidity contract statement with details of shares and executed trades, complying with AMF regulations Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech AMF Regulations
BRIEF published on 01/06/2025 at 11:08, 1 year ago Number of shares and voting rights of Sartorius Stedim Biotech Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights in their issued capital according to regulations Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital as of December 31, 2024 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
BRIEF published on 12/03/2024 at 10:43, 1 year 1 month ago Sartorius Stedim Biotech Statement on Share Capital Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in Aubagne, France declares total shares and voting rights as of November 30, 2024 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
Published on 01/30/2026 at 14:00, 2 hours 57 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 8 hours 22 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 57 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 14 hours 42 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 57 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 16:46, 10 minutes ago Custodian Property Income REIT plc: Investor Presentation via Investor Meet Company
Published on 01/30/2026 at 16:00, 57 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:57, 59 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 18:00, 22 hours 57 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 23 hours 12 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 23 hours 12 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
